<SEC-DOCUMENT>0001144204-18-065270.txt : 20181219
<SEC-HEADER>0001144204-18-065270.hdr.sgml : 20181219
<ACCEPTANCE-DATETIME>20181219070039
ACCESSION NUMBER:		0001144204-18-065270
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20181219
DATE AS OF CHANGE:		20181219
EFFECTIVENESS DATE:		20181219

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protalix BioTherapeutics, Inc.
		CENTRAL INDEX KEY:			0001006281
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				650643773
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33357
		FILM NUMBER:		181242189

	BUSINESS ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100
		BUSINESS PHONE:		972-4-988-9488

	MAIL ADDRESS:	
		STREET 1:		2 SNUNIT ST
		STREET 2:		SCIENCE PARK, POB 455
		CITY:			CARMIEL
		STATE:			L3
		ZIP:			20100

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHODONTIX INC
		DATE OF NAME CHANGE:	19980422

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EMBASSY ACQUISITION CORP
		DATE OF NAME CHANGE:	19960124
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>tv509397_defa14a.htm
<DESCRIPTION>DEFA14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">



<P STYLE="margin: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section&nbsp;14(a)
of the Securities Exchange Act of 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Filed by the Registrant&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#120;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Filed by a Party other than
the Registrant&nbsp;&nbsp;<FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Preliminary Proxy Statement </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) </B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Definitive Proxy Statement </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Definitive Additional Materials </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Soliciting Material Pursuant to &sect;240.14a-12</FONT></TD></TR>
</TABLE>
<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Protalix BioTherapeutics, Inc. </B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>








<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Registrant as Specified In
Its Charter)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 12.2pt; text-indent: -12.25pt">Payment of Filing Fee (Check
the appropriate box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#120;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">No fee required. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%; font-size: 10pt"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Title of each class of securities to which transaction applies: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Aggregate number of securities to which transaction applies: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">forth the amount on which the filing fee is calculated and state how it was determined):</FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Proposed maximum aggregate value of transaction: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">5)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Total fee paid: </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Fee paid previously with preliminary materials. </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 4%"><FONT STYLE="font: 10pt Wingdings"><FONT STYLE="font-family: Wingdings">&#168;</FONT></FONT></TD>
    <TD><FONT STYLE="font-size: 10pt">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.&nbsp;&nbsp;Identify the previous filing by registration statement number, or the form or schedule and the date of its filing: </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 3%"><FONT STYLE="font-size: 10pt">1)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Amount Previously Paid: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">2)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Form, Schedule or Registration Statement No: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">3)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Filing Party: </FONT></TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top"><FONT STYLE="font-size: 10pt">4)</FONT></TD>
    <TD STYLE="vertical-align: top; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Date Filed: </FONT></TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 1; Options: NewSection -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%">&nbsp;</TD><TD STYLE="width: 33%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><IMG SRC="image_001.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U>Protalix Biotherapeutics Inc. Announces
Adjournment of Special Meeting of Stockholders</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Protalix Biotherapeutics, Inc. has announced
that the December 13<SUP>th</SUP>, 2018 Special Meeting of Stockholders has been adjourned until January 10<SUP>th</SUP>, 2019
to allow additional time for stockholders to vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Given the importance of the proposal to
be voted on at the meeting, we want to ensure that all stockholders have sufficient time to have their vote represented. This adjournment
provides our stockholders additional time to vote on an amendment to our Certificate of Incorporation that increases the number
of shares of Protalix Biotherapeutics common stock authorized for issuance from 250 million to 350 million.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Special Meeting is scheduled to reconvene
on Thursday, January 10<SUP>th</SUP>, 2019 at 1:00pm IDT at the offices of our Israeli counsel, Horn &amp; Co., Law Offices, Amot
Investments Tower, 2 Weizmann Street, 24th Floor, Tel Aviv 6423902, Israel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; background-color: Silver">
<TR>
    <TD STYLE="border: Black 1pt solid">
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><I>Your participation in the Special
        Meeting is critical and <U>your account is currently unvoted.</U><BR>
        Please vote your shares of stock now so that your vote can be counted without delay.</I></B></P></TD></TR>
</TABLE>
<P STYLE="margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you have any questions or require further assistance in voting
your shares, please contact our proxy solicitor Alliance Advisors toll-free at <FONT STYLE="font-size: 10pt"><B>1-833-786-6488</B></FONT>
if in the United States, or <FONT STYLE="font-size: 10pt"><B>973-873-7780</B></FONT> if dialing internationally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Sincerely,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><I>[s] </I> Yossi Maimon</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Yossi Maimon</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Vice President and Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<DIV STYLE="padding: 1pt 4pt; border: Black 1pt solid">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IF YOU HAVE RECENTLY MAILED YOUR PROXY
CARD OR CAST YOUR VOTE BY </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PHONE OR INTERNET, PLEASE ACCEPT OUR
THANKS AND DISREGARD THIS REQUEST.</B></P>

</DIV>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><U></U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 4%">&nbsp;</TD><TD STYLE="width: 92%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">2 Snunit Street, Science Park P.O.B. 455, Carmiel 20100, Israel</P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Tel: 972-4-988-9488 | Fax: 972-4-988-9489 | Web: www.protalix.com</P></TD><TD STYLE="width: 4%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>





</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !# .,# 2(  A$! Q$!_\0
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MI_\ PDG_  G'B/\ X1OR_.^U2^;OV?=\QL?>]ZZ$1?%"<&-IK6$,,;_W7'Y
MTG@7_DH7BO\ Z[R?^C6KTF@#B?"W@-]+U,ZSK-Y]NU,Y(.250D8)R>6...V*
MS/BE_P A;PQ_UWD_]"BKTFO-OBE_R%O#'_7>3_T**@#>\9>*K_PLL-Q'IB75
MG)\K2^:5*/Z$8/4=#]:Y*23QA\1+6*-88;'1Y#EI%;Y7P>_.6Y'3@9'->GW]
MA;:G8365W&)()EVNI_SUKS#0K^Y^'GBB30]3D+:5<MNAF/1<\!_IV8=L9^H!
MVMQX>AT[P'>:-8*Q M)%4G[SN5)R?J:QOA/>1S>%9;93^]M[AMR^S $'^?Y5
MW@.1D=*\KU:SO_AYXGDUO3X3-H]VV)HEZ)DYVGTY^Z?P^H!ZI16-HWBK1M=@
M5[.]BWD<PR,%D7ZJ?YCBKE_J^G:7$TE]>P6ZC_GHX!/T'4_A0!!XCO(]/\-Z
ME=2$!4MWQGN2, ?B2!7,?":W>'PC)*X($]T[ISU "K_-36%K6L7OQ'U./1=$
MC>/3(G#SW#C /^T?0=<+U)_3T[3M/@TK3K>QM5VPP($4'K]3[GK0!P'Q2_Y"
MWAC_ *[R?^A15Z37FWQ2_P"0MX8_Z[R?^A15V^OZM'H>A7>HR8/DQDJ#_$QX
M4?B2* /*OB)K]O>^,K>TF#2V&G,!+&AY=B07'Y +^!K>'Q@T\# TJYQ_UT6K
M'PMTF1-.NM=NLM<W\AVLW4J#R?Q;/Y"O0: /"'\7VR^/X?$-E;R6\3LOVB-B
M#N!&U\8]1S]:]U1UD171@RL 01T(KG_&^B?V[X6NK=%W7$0\Z#CG<O8?49'X
MUG?#/7/[5\,):R/FXL2(6SU*?P'\N/\ @- &)X>_Y++K/^Y)_-*].KS'P]_R
M676?]R3^:5Z=0!@>-_\ D2M6_P"N!_F*S_AE_P B-9_]=)/_ $,UH>-_^1*U
M;_K@?YBL_P"&7_(C6?\ UTD_]#- '7UR/CW5-.@T=K&XC6>ZEYBCSS&?[Y].
M_P!?IFM#Q/XF@\/V>!B2\D'[J+T_VC[?SKG?#/AYYY7\1^(6RQ_>H)CC'^VW
MH/0?_6K2*M[S/+QM=U&\+1UD]WTBO/S[%_P39WFC:%-=:G.8;5AYB0R?\LU[
ML?3/I7$:I$=?U2_OM'TYUM8AODVC_P >([$]<#W]ZW;_ %"^\=ZO_9NGYBTV
M([G<]Q_>;^@_R.]TG2;71K!+2T3:@Y9CU<^I/K5<W*[O=G#'#+&05"F_W4/M
M=6_+R,/P+JFG76C)9VJ+!<0C,L7=CW?WS^G3TKJJ\_\ %/ANXTJ[&O:$&C:,
M[Y8X_P"'U8#T]1_2ND\->)+?Q!9;EQ'=1@>=#GI[CVJ9*_O([\'7E3E]5K*T
MEMVDO+S[HW****S/3,'1_"MKHVMZCJD,\SRW[L[H^-JDL6XP/>MZO/-)T_5O
M$&IZY*/$FHVBVNI301QQME0H/'!_E6IH&HZM8^*+CPWJ]TM[BW%S;700*Q7.
M"& []?R]Z .OK!\0^%;7Q'<Z?/<SS1-9.SH(\88DJ><C_9%)IK71\8:V)-0C
MEMPL/E6HERT/R<Y7^')Y]ZTM1U?3M)C634+V"V5ON^8X!;Z#J: +M8OB3PS8
M^)[%+:\WHT;;HY8\;D]<9[&KFG:UIFKJQT^^@N=OWA&X)'U'45S_ (_U^+3?
M#EY!;ZBMOJ96-HD23;)CS%R1WZ;OUH Z#1]..DZ7#8_:IKE81M1YL;MO8<>E
M7)(TEC:.1%=&&&5AD$>A%<UJ.OVMWX/U.?2]1CEN+>T+,\$F6C8J<'CH>#^5
M+IOBO2;30M*&IZM MW)9PO()),N24!);ZYSS0!2U+X8>';^1I(HY[-CR1;N
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MW5]*N^XN9;)I&=SR<$CI3M/U*QM?&]E-H%I>6]I?$Q7L#6[1Q@_PN!T!R?\
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J_P#8.C_]"%%% '7T444 %%%% !1110 4444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
